Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
Conditions
Interventions
Empasiprubart IV
Placebo IV
Locations
28
United States
Profound Research LLC
Oceanside, California, United States
Omega Research Debary, LLC
DeBary, Florida, United States
University of Florida Health (UF) - Endocrinology - Medical Specialties - Medical Plaza
Gainesville, Florida, United States
Homestead Associates in Research, Inc.
Homestead, Florida, United States
Life Clinical Trials
Margate, Florida, United States
Advance Medical Research Center
Miami, Florida, United States
Start Date
August 20, 2024
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2026
Last Updated
September 25, 2025
NCT00017914
NCT07089121
NCT04402086
NCT07160205
NCT07374107
NCT06479863
Lead Sponsor
argenx
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions